Royal Bank Of Canada restated their outperform rating on shares of Diploma (LON:DPLM – Free Report) in a report issued on Tuesday morning,Digital Look reports. They currently have a GBX 7,400 price objective on the stock.
A number of other equities research analysts also recently commented on DPLM. Deutsche Bank Aktiengesellschaft boosted their target price on Diploma from GBX 6,400 to GBX 7,200 and gave the stock a “buy” rating in a research report on Wednesday, May 20th. Jefferies Financial Group reaffirmed a “hold” rating and issued a GBX 7,000 price objective on shares of Diploma in a research note on Friday, May 29th. JPMorgan Chase & Co. upped their price objective on Diploma from GBX 5,760 to GBX 8,250 and gave the stock an “overweight” rating in a report on Monday, August 24th. Finally, Berenberg Bank reissued a “buy” rating and issued a GBX 9,000 target price on shares of Diploma in a report on Monday, July 20th. Six equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Diploma currently has a consensus rating of “Moderate Buy” and an average target price of GBX 7,400.
Get Our Latest Stock Report on DPLM
Diploma Stock Down 0.6%
Insider Buying and Selling
In related news, insider Mandy Gradden acquired 1,000 shares of Diploma stock in a transaction on Friday, July 17th. The shares were bought at an average cost of GBX 7,183 per share, with a total value of £71,830. Also, insider Wilson Ng acquired 424 shares of the firm’s stock in a transaction on Thursday, July 16th. The shares were bought at an average price of GBX 7,066 per share, for a total transaction of £29,959.84. Over the last quarter, insiders purchased 1,604 shares of company stock worth $11,447,718. Corporate insiders own 1.14% of the company’s stock.
About Diploma
Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.
Featured Articles
- Five stocks we like better than Diploma
- Tesla’s Robotaxi Launch Wasn’t the Moment Investors Expected
- Despite Post-Earnings Drop, Wall Street Analysts Eye New Highs for Broadcom Stock
- Morgan Stanley Eyes Good Things Ahead for Meta After $18 Billion Legal Settlement
- Q3 Earnings Could Be the Catalyst the Market Has Been Waiting For
Receive News & Ratings for Diploma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diploma and related companies with MarketBeat.com's FREE daily email newsletter.
